MERCK KGAA NAM.SP.ADR Asset Resilience Ratio

Latest as of December 2025: 1.16%

MERCK KGAA NAM.SP.ADR asset resilience ratio. MERCK KGAA NAM.SP.ADR (MRKC) has an Asset Resilience Ratio of 1.16% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read MRKC total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets

€597.00 Million
≈ $697.96 Million USD Cash + Short-term Investments

Total Assets

€51.53 Billion
≈ $60.24 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of MERCK KGAA NAM.SP.ADR (2020–2025)

Asset resilience ratio of MERCK KGAA NAM.SP.ADR from 2020 to 2025. This chart shows how MERCK KGAA NAM.SP.ADR's Asset Resilience Ratio has changed over time. See MRKC free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Liquid Assets Composition Over Time

This chart breaks down MERCK KGAA NAM.SP.ADR's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see MRKC total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €597.00 Million 1.16%
Total Liquid Assets €597.00 Million 1.16%

Asset Resilience Insights

  • Limited Liquidity: MERCK KGAA NAM.SP.ADR maintains only 1.16% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

MERCK KGAA NAM.SP.ADR Industry Peers by Asset Resilience Ratio

Compare MERCK KGAA NAM.SP.ADR's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Curaleaf Holdings Inc.
TO:CURA
Drug Manufacturers - Specialty & Generic 3.73%
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Drug Manufacturers - Specialty & Generic 5.90%
Zhejiang Medicine Co Ltd
SHG:600216
Drug Manufacturers - Specialty & Generic 1.85%
Hunan Warrant Pharmaceutical Co. Ltd. A
SHG:688799
Drug Manufacturers - Specialty & Generic 0.40%
Dezhan HealthCare Co Ltd
SHE:000813
Drug Manufacturers - Specialty & Generic 0.09%
Chongqing Pharscin Pharmaceutical Co Ltd
SHE:002907
Drug Manufacturers - Specialty & Generic 14.54%

MERCK KGAA NAM.SP.ADR Asset Resilience Ratio by Year (2020–2025)

MERCK KGAA NAM.SP.ADR asset resilience ratio by year from 2020 to 2025. The table below shows the annual Asset Resilience Ratio data for MERCK KGAA NAM.SP.ADR.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 1.16% €597.00 Million
≈ $697.96 Million
€51.53 Billion
≈ $60.24 Billion
+0.08pp
2024-12-31 1.08% €558.00 Million
≈ $652.36 Million
€51.57 Billion
≈ $60.29 Billion
+0.19pp
2023-12-31 0.89% €431.00 Million
≈ $503.88 Million
€48.49 Billion
≈ $56.70 Billion
+0.39pp
2022-12-31 0.50% €244.00 Million
≈ $285.26 Million
€48.53 Billion
≈ $56.74 Billion
+0.26pp
2021-12-31 0.25% €112.00 Million
≈ $130.94 Million
€45.36 Billion
≈ $53.03 Billion
+0.18pp
2020-12-31 0.07% €29.00 Million
≈ $33.90 Million
€41.80 Billion
≈ $48.86 Billion
--
pp = percentage points

About MERCK KGAA NAM.SP.ADR

F:MRKC Germany Drug Manufacturers - Specialty & Generic
Market Cap
$17.07 Billion
€14.60 Billion EUR
Market Cap Rank
#1439 Global
#324 in Germany
Share Price
€22.60
Change (1 day)
-2.59%
52-Week Range
€20.20 - €26.20
All Time High
€44.30
About

Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. This segment offers science and lab solutions comprising reagents, consumables,… Read more